# Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

> **NCT01486550** · PHASE4 · TERMINATED · sponsor: **Regional Hospital Holstebro** · enrollment: 14 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** Voluven (Hydroxyethyl starch 130/0,4)
- **DRUG:** Sodium Chloride 9mg/ml

## Key facts

- **NCT ID:** NCT01486550
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Lack of patient enrollment
- **Last updated:** 2014-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486550, "Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01486550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*